People · Operator
Named in public records as an officer, director or promoter · active 2012–2015 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| InspireMD, Inc. | — | Other Health Care | Series C | $117.2M | $248.3M | 2012 |
| Edge Therapeutics, Inc. | — | Pharmaceuticals | Series C | $72.1M | $2.0B | 2012 |
James J. Loughlin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James J. Loughlin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sol J. Barer | 2 | 6 |
| Sol Barer | 2 | 6 |
| Isaac Blech | 1 | 14 |
| Michael Berman | 1 | 7 |
| James Barry | 1 | 5 |
| Asher Holzer | 1 | 4 |
| Eli Bar | 1 | 3 |
| Isaac J. Blech | 1 | 3 |
| Eyal Weinstein | 1 | 2 |
| Kurt Conti | 1 | 2 |
| Robert J. Spiegel | 1 | 2 |
| James J. Barry | 1 | 2 |
| Scott R. Ward | 1 | 2 |
| Alan Milinazzo | 1 | 2 |
| Ofir Paz | 1 | 2 |
| Paul Stuka | 1 | 2 |
| Craig Shore | 1 | 1 |
| Kurt J. Conti | 1 | 1 |
| Carl J. Soranno | 1 | 1 |
| Robert Loch Macdonald | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.